Clinical trials
Active, not recruiting Uterine Cervical Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 1 |
| Alterome Therapeutics, Inc. | 1 |
| Atavistik Bio, Inc | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Centre Regional de Coordination des Depistages des Cancer - Pays de la Loire | 1 |
| Eli Lilly and Company | 1 |
| Grey Wolf Therapeutics | 1 |
| Innate Pharma | 1 |
| Institut Paoli-Calmettes | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 15 |
| Endometrial Neoplasms | 6 |
| Ovarian Neoplasms | 5 |
| Triple Negative Breast Neoplasms | 5 |
| Prostatic Neoplasms | 4 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.